AstraZeneca PLC (ZEG.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 07:15PM CEST. Market open.
| Previous close | 142.40 |
| Open | 141.45 |
| Bid | 139.80 x 40000 |
| Ask | 141.15 x 40000 |
| Day's range | 139.75 - 141.60 |
| 52-week range | 112.45 - 158.15 |
| Volume | |
| Avg. volume | 582 |
| Market cap | 216.653B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 37.17 |
| EPS (TTM) | 3.76 |
| Earnings date | 12 Nov 2024 |
| Forward dividend & yield | 2.73 (1.92%) |
| Ex-dividend date | 08 Aug 2024 |
| 1y target est | N/A |
ZacksAstrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Astrazeneca (AZN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ZacksAstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
AZN inks an agreement with CSPC Pharmaceutical to develop a novel lipid-lowering therapy targeting various cardiovascular diseases.
ZacksZacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer have been highlighted in this Industry Outlook article.
© 2024 Yahoo. All rights reserved.